Bize Ulaşın 0533 482 66 72

Uluslararası Platformlardaki Yayınlar

  1. Thrombin-receptor antagonist vorapaxar in acute coronary syndromes.
  2. The particular interactions of the traditional cardiovascular risk factors with different circulating specific leukocyte subtype counts in blood: an observational study.
  3. [The relation of serum monocyte chemoattractant protein-1 level with coronary atherosclerotic burden and collateral degree in stable coronary artery disease].
  4. Plasma neutrophil gelatinase-associated lipocalin levels in acute myocardial infarction and stable coronary artery disease.
  5. Endothelial progenitor cells (CD34+KDR+) and monocytes may provide the development of good coronary collaterals despite the vascular risk factors and extensive atherosclerosis.
  6. Relation between serum monocyte chemoattractant protein-1 and coronary collateral development.
  7. [What is renin inhibition? Mechanism of action].
  8. [Transradial approach in diagnostic and therapeutic interventional coronary artery procedures].
  9. Impact of the lesion location on fractional flow reserve.
  10. The Thrombin Receptor Antagonist for Clinical Event Reduction in Acute Coronary Syndrome (TRA*CER) trial: study design and rationale.
  11. Independent relationship of serum uric acid levels with leukocytes and coronary atherosclerotic burden.
  12. The comparison of early and late outcome of direct and conventional stenting of patients with st elevation myocardial infarction.
  13. The reliability of fractional flow reserve measurement in patients with diabetes mellitus.
  14. The impact of multiple vessel disease on fractional flow reserve.
  15. Long-term clinical effects of magnetic resonance imaging in patients with coronary artery stent implantation.
  16. The association of circulating monocyte count with coronary collateral growth in patients with diabetes mellitus.
  17. Spontaneous coronary vasospasm in the catheterisation laboratory: prompt resolution after atropine injection.
  18. Asymmetric dimethylarginine and coronary collateral vessel development.
  19. Intracoronary thrombus aspiration through a guiding catheter in a case with stent thrombosis.
  20. Corrected thrombolysis in myocardial infarction frame counts in diabetic patients with angiographically normal coronary arteries.
  21. The delta fractional flow reserve can predict lesion severity and long-term prognosis.
  22. Traditional risk factors are predictive on segmental localization of coronary artery disease.
  23. E-page Original Images. The accordion phenomenon.
  24. The optimal time of elective percutaneous coronary intervention for stable patients after ST elevation myocardial infarction.
  25. Plasma homocysteine level in cardiac syndrome X and its relation with duke treadmill score.
  26. Long term tirofiban infusion before percutaneous coronary intervention in patients with angiographically massive intracoronary thrombus.
  27. Myocardial blush grade: a predictor for major adverse cardiac events after primary PTCA with stent implantation for acute myocardial infarction.
  28. Metoprolol does not effect myocardial fractional flow reserve in patients with intermediate coronary stenoses.
  29. Hypertension as a predictor of adverse cardiac events in patients with borderline fractional flow reserve.
  30. Spontaneous multivessel coronary artery dissection in a wrestler.
  31. Coincidental diagnosis of corrected transposition of the great arteries in an asymptomatic 65-year-old patient.
  32. The clinical outcomes of percutaneous coronary intervention in chronic total coronary occlusion.
  33. Spontaneous coronary vasospasm in the catheterisation laboratory: prompt resolution after atropine injection.
  34. Plasma asymmetric dimethylarginine level and extent of lesion at coronary angiography.
  35. Role of tirofiban in treatment of stent thrombosis.
  36. B-type natriuretic peptide and extent of lesion on coronary angiography in stable coronary artery disease.
  37. Prospective randomized trial of transthoracic versus low-energy transvenous internal cardioversion in persistent atrial fibrillation.
  38. Detection of stent restenosis in single vessel CAD: comparison of 201Tl and gated 99mTc-MIBI SPECT.
  39. Dissection of the sinus of valsalva during coronary angiography in a patient with spontaneous coronary artery dissection.
  40. Early and late outcome of stenting in a consecutive series of patients with coronary lesions in vessels less than 2.8 mm in diameter.
  41. Acute myocardial infarction secondary to thyrotoxicosis.
  42. Head-to-head comparison of two different low-molecular-weight heparins in acute coronary syndrome: a single center experience.
  43. Medium-term follow-up of intermediate coronary stenoses left unrevascularized based on myocardial fractional flow reserve findings.
  44. Covered stent graft for primary PTCA of an aortocoronary vein graft.
  45. Frequency of cardiac troponin-t elevation after successful direct stenting.
  46. Sidebranch occlusion after coronary stenting with or without balloon predilation: direct versus conventional stenting.
  47. Conventional versus direct stenting in AMI: effect on immediate coronary blood flow.
  48. Double right coronary artery with atherosclerosis: a rare coronary artery anomaly.
  49. Recanalization of an occluded major side branch after stenting with intracoronary adenosine.
  50. Effects of left ventricular systolic dysfunction on left atrial appendage and left atrial functions in patients with chronic nonvalvular atrial fibrillation.
  51. Amplatzing a 6 Fr Judkins right guiding catheter for increased success in complex right coronary artery anatomy.
  52. Myocardial injury after apparently successful coronary stenting with or without balloon dilation: direct versus conventional stenting.
  53. Use of a 0.014 in. guidewire for cannulation of left coronary ostium with a difficult anatomy.
  54. Coronary artery perforation: a rare complication of coronary angiography.
  55. Direct stenting in angiographically apparent thrombus-containing lesions.
  56. Stenting of the septal perforator coronary artery.
  57. Adjunctive therapies in the cath lab. Intracoronary tirofiban infusion in a case with massive intracoronary thrombus.
  58. Adjunctive therapies in the cath lab. Subacute stent thrombosis developing twelve days after discontinuation of ticlopidine treatment.
  59. Primary angioplasty and stenting in a patient with primary antiphospholipid syndrome and thrombocytopenia.
  60. Pentacuspid aortic valve diagnosed by transoesophageal echocardiography.
  61. Optimal stent positioning in coronary arteries: partial balloon inflation to overcome cardiac cycle-related motion of the stent/delivery system.
  62. Early clinical experience with the implantation of a novel synthetic coronary stent graft.
  63. Acute occlusion of the left main coronary artery following intracoronary ultrasound examination.
  64. Left atrial free floating thrombus. Diagnosis by two dimensional and M-mode echocardiography.